Progestins and antiprogestins

00:00 / 00:00

Questions

USMLE® Step 2 style questions USMLE

of complete

A 30-year-old woman comes to the office after a positive home pregnancy test, which she took after missing her period. The patient has not had any recent vaginal bleeding or abdominal cramping. Menarche was at age 12 years, and she reports having a regular 28-day menstrual cycle. Past medical history is unremarkable, and the patient does not take any medications. Family history is noncontributory. Vitals are within normal limits. Physical examination shows a small, mobile, nontender uterus. A transvaginal ultrasound confirms a 7-week fetus. The patient describes her wish to terminate the pregnancy and opts for medical abortion. Which of the following is the most appropriate abortive agent for this patient?  

Memory Anchors and Partner Content

External References

First Aid

2024

2023

2022

2021

Contraception

progestins for p. 675

Endometrial carcimoma p. 658

progestins for p. 675

Progestins p. 675

endometriosis p. 658

External Links

Transcript

Watch video only

Progestins are a group of synthetic progestogens that have similar effects to those of natural progesterone.

They can be divided into two categories: the progesterone derivatives and the testosterone derivatives.

They are mainly used as contraceptives, in hormone replacement therapy, or HRT, and in the treatment of various gynecologic conditions.

Now, antiprogestins act as progesterone antagonists and include mifepristone and ulipristal.

Mifepristone is used for medical abortion while ulipristal is used as an emergency contraceptive.

The hypothalamus secretes gonadotropin-releasing hormone, or GnRH, which travels to the nearby pituitary gland and stimulates it to secrete two hormones, follicle stimulating hormone, or FSH, and luteinizing hormone, or LH.

During the two weeks following ovulation, which is referred to as the ovarian luteal phase, the remnant of the ovarian follicle becomes the corpus luteum, which is made up of luteinized theca and granulosa cells, meaning that these cells have been exposed to the high luteinizing hormone levels that occur just before ovulation.

The luteinized cells secrete more progesterone than estrogen and progesterone becomes the dominant hormone.

Under the influence of progesterone, the uterus enters into the secretory phase of the endometrial cycle.

During this time, spiral arteries continue to grow, and the endometrial glands continue to produce more secretions that make the endometrium more receptive to the implantation of a fertilized gamete.

After day 15 of the cycle, the optimal window for fertilization begins to close and the corpus luteum gradually degenerates into the nonfunctional corpus albicans.

The corpus albicans doesn’t make hormones, so estrogen and progesterone levels slowly decrease.

When progesterone reaches its lowest level, the spiral arteries collapse and the functional layer of the endometrium prepares to shed during menstruation.

Summary

Progestins are synthetic that mimic the effects of progesterone, a hormone that plays a role in the menstrual cycle and pregnancy. Common uses of progestins include hormonal contraception (either alone or with estrogen), and prevention of endometrial hyperplasia from unopposed estrogen in hormone replacement therapy. Progestins are also used to treat secondary amenorrhea, dysfunctional uterine bleeding, endometriosis, and breast cancer. On the other hand, antiprogestins are drugs that block the effects of progesterone. Antiprogestins are used in pregnancy termination and emergency contraception.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells" Endocrinology (2018)
  5. "Antiprogestins in gynecological diseases" REPRODUCTION (2015)
  6. "An efficient model of human endometriosis by induced unopposed estrogenicity in baboons" Oncotarget (2016)
Elsevier

Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX